Good morning :)
Place Order
Add to Watchlist

Colinz Laboratories Ltd

COLINZ Share Price

58.912.00% (-1.20)
High
—
—
Low
—
—
Returns
—
—
1D
1W
1M
1Y
5Y
Max
SIP
Loading...
1D
1W
1M
1Y
5Y
Max
SIP
Health Care
Pharmaceuticals
Smallcap

With a market cap of ₹14 cr, stock is ranked 4,370

High Risk

Stock is 4.99x as volatile as Nifty

COLINZ Stock Scorecard

Performance

Avg

Price return has been average, nothing exciting

Valuation

High

Seems to be overvalued vs the market average

Growth

Low

Lagging behind the market in financials growth

Profitability

High

Showing good signs of profitability & efficiency

Entry point

Avg

The stock is not in the overbought zone

Red flags

Low

No red flag found

How to use scorecard? Learn more

Health Care
Pharmaceuticals
Smallcap

With a market cap of ₹14 cr, stock is ranked 4,370

High Risk

Stock is 4.99x as volatile as Nifty

COLINZ Performance & Key Metrics

COLINZ Performance & Key Metrics

No LabelNo LabelPB RatioPB RatioDividend YieldDiv. Yield
29.681.66—
Sector PESector PESector PBSector PBSector Div YldSctr Div Yld
36.026.630.84%

COLINZ Analyst Ratings & Forecast

—
Analyst Ratings data is currently unavailable for this stock

Price Upside

Earnings Growth

Rev. Growth

COLINZ Company Profile

Colinz Laboratories Ltd is engaged in the manufacturing and marketing of pharmaceutical formulations.

COLINZ Similar Stocks (Peers)

Compare with peers Compare with peers 

COLINZ Similar Stocks (Peers)

Compare with peers Compare with peers 
Sun Pharmaceutical Industries Ltd
SUNPHARMA
PE Ratio
37.08
37.08
1Y Return
11.61%
11.61%
Buy Reco %
87.88
87.88
Cipla Ltd
CIPLA
PE Ratio
23.14
23.14
1Y Return
1.53%
1.53%
Buy Reco %
74.19
74.19
Dr Reddy's Laboratories Ltd
DRREDDY
PE Ratio
19.85
19.85
1Y Return
10.45%
10.45%
Buy Reco %
56.67
56.67
Torrent Pharmaceuticals Ltd
TORNTPHARM
PE Ratio
57.05
57.05
1Y Return
12.47%
12.47%
Buy Reco %
72.00
72.00
Zydus Lifesciences Ltd
ZYDUSLIFE
PE Ratio
21.83
21.83
1Y Return
9.60%
9.60%
Buy Reco %
48.28
48.28
Compare with Peers

COLINZ Forecast

COLINZ Forecasts

empty forecast

Forecast data is currently unavailable

Forecast data is currently unavailable

Price

Price Upside

Revenue

Revenue Growth

Earnings

Earnings Per Share

COLINZ

COLINZ

Income

Balance Sheet

Cash Flow

COLINZ Income Statement

COLINZ Income Statement

Industry refers to the sub-sector this company belongs to.
Lower than Industry Revenue Growth
A higher-than-industry revenue growth represents increased potential for the company to increase their market share

Over the last 5 years, revenue has grown at a yearly rate of -1.06%, vs industry avg of 9.02%

Constant Market Share
Market share is the percentage of an industry's total sales going to a particular company. It gives a general idea of the size of a company v/s its competitors

Over the last 5 years, market share stayed at 0%

Higher than Industry Net Income
Net income is equal to net earnings (profit) less expenses. This number is an important measure of how profitable the company is

Over the last 5 years, net income has grown at a yearly rate of 34.82%, vs industry avg of 15.29%

Loading...

Financial YearFY 2017FY 2018FY 2019FY 2020FY 2021FY 2022FY 2023FY 2024FY 2025TTM
Total Revenue8.147.937.717.666.357.147.327.316.836.82
Raw Materialssubtract2.882.602.732.621.721.972.332.236.036.03
Power & Fuel Costsubtract0.080.080.100.090.080.080.110.11
Employee Costsubtract2.913.153.073.252.392.772.902.79
Selling & Administrative Expensessubtract1.531.221.161.080.961.031.081.10
Operating & Other expensessubtract0.240.420.180.190.680.540.130.25
Depreciation/Amortizationsubtract0.270.220.220.190.190.200.130.130.130.12
Interest & Other Itemssubtract0.120.080.100.070.090.080.050.040.040.05
Taxes & Other Itemssubtract-0.03-0.080.040.050.040.140.140.170.120.12
EPS0.400.680.310.340.490.721.271.951.971.98
DPS0.000.000.000.000.000.000.000.000.000.00
Payout ratio0.000.000.000.000.000.000.000.000.000.00
See Costs

EPS and DPS in ₹. Other numbers except Payout Ratio in ₹ cr

COLINZ Company Updates

Annual Report and Investor Presentation updates mentioned here are as reported by the company to the exchange
FY 2024FY 2024

Annual report

PDF
FY 2023FY 2023

Annual report

PDF
FY 2022FY 2022

Annual report

PDF
FY 2021FY 2021

Annual report

PDF
FY 2020FY 2020

Annual report

PDF
FY 2019FY 2019

Annual report

PDF
FY 2018FY 2018

Annual report

PDF
FY 2017FY 2017

Annual report

PDF
FY 2016FY 2016

Annual report

PDF
FY 2015FY 2015

Annual Report Unavailable

FY 2014FY 2014

Annual report

PDF
 

COLINZ Stock Peers

COLINZ Past Performance & Peer Comparison

COLINZ Past Performance & Peer Comparison

Comparing 3 stocks from 
Health CarePharmaceuticals

Valuation

Technical

Forecast

ScreenerCompare valuation on Screener

Loading...

StockPE RatioPE RatioPB RatioPB RatioDiv. YieldDividend Yield
Colinz Laboratories Ltd29.101.66—
Sun Pharmaceutical Industries Ltd37.086.040.95%
Cipla Ltd23.144.551.06%
Dr Reddy's Laboratories Ltd19.853.970.59%

COLINZ Stock Price Comparison

Compare COLINZ with any stock or ETF
Compare COLINZ with any stock or ETF
COLINZ
Loading...

COLINZ Holdings

COLINZ Shareholdings

COLINZ Promoter Holdings Trend

COLINZ Promoter Holdings Trend

Total Promoter Holding
Increasing promoter holding is considered good and reflects management’s positive view about the future outlook

In last 6 months, promoter holding in the company has almost stayed constant

Low Pledged Promoter Holding
Lower pledged promoter holdings is considered better

Pledged promoter holdings is insignificant

COLINZ Institutional Holdings Trend

COLINZ Institutional Holdings Trend

Total Retail Holding
Increasing retail holding can be considered bad as it can reflect that institutions and promoters are selling their stake which is being absorbed by retail investors.

In last 3 months, retail holding in the company has almost stayed constant

Foreign Institutional Holding
Foreign Institutional Holding is quantum of stock held by foreign large-quantities-trading entities. Increasing value indicates growing support and comfort for the stock

In last 3 months, foreign institutional holding of the company has almost stayed constant

Tickertape Separator

COLINZ Shareholding Pattern

COLINZ Shareholding Pattern

Retail and OthersForeign InstitutionsOther Domestic InstitutionsMutual FundsTotal Promoter Holding65.94%0.00%0.00%0.00%34.06%

Jun 2024

Sep 2024

Dec 2024

Mar 2025

COLINZ Shareholding History

COLINZ Shareholding History

Dec '23MarJunSepDec '24Mar0.00%0.00%0.00%0.00%0.00%0.00%

COLINZ Insider Trades & Bulk Stock Deals

COLINZ Insider Trades & Bulk Stock Deals

Loading...

smallcases containing COLINZ stock

smallcases containing COLINZ stock

Looks like this stock is not in any smallcase yet.

COLINZ Events

COLINZ Events

COLINZ Dividend Trend

No Dividends
Dividends are the portion of earnings that a company distributes to all its shareholders every year

COLINZ has not given any dividends in last 5 years

Dividends

Corp. Actions

Announcements

Legal Orders

COLINZ Dividend Trend

No Dividends
Dividends are the portion of earnings that a company distributes to all its shareholders every year

COLINZ has not given any dividends in last 5 years

COLINZ Dividends

COLINZ Dividends

Hmm, looks like data is unavailable here. Please come back after some time

COLINZ Stock News & Opinions

COLINZ Stock News & Opinions

Earnings
Colinz Laboratories standalone net profit rises 7.14% in the March 2025 quarter

Net profit of Colinz Laboratories rose 7.14% to Rs 0.15 crore in the quarter ended March 2025 as against Rs 0.14 crore during the previous quarter ended March 2024. Sales declined 11.04% to Rs 1.45 crore in the quarter ended March 2025 as against Rs 1.63 crore during the previous quarter ended March 2024. For the full year,net profit rose 2.04% to Rs 0.50 crore in the year ended March 2025 as against Rs 0.49 crore during the previous year ended March 2024. Sales declined 7.11% to Rs 6.53 crore in the year ended March 2025 as against Rs 7.03 crore during the previous year ended March 2024. ParticularsQuarter EndedYear EndedMar. 2025Mar. 2024% Var.Mar. 2025Mar. 2024% Var. Sales1.451.63 -11 6.537.03 -7 OPM %6.217.98 -7.507.82 - PBDT0.150.23 -35 0.750.79 -5 PBT0.120.20 -40 0.620.66 -6 NP0.150.14 7 0.500.49 2 Powered by Capital Market - Live

3 weeks agoCapital Market - Live
Corporate
Colinz Laboratories to conduct board meeting

Colinz Laboratories will hold a meeting of the Board of Directors of the Company on 16 May 2025.Powered by Capital Market - Live

1 month agoCapital Market - Live
Corporate
Colinz Laboratories to announce Quarterly Result

Colinz Laboratories will hold a meeting of the Board of Directors of the Company on 16 May 2025.Powered by Capital Market - Live

1 month agoCapital Market - Live
Earnings
Colinz Laboratories standalone net profit declines 54.55% in the December 2024 quarter

Net profit of Colinz Laboratories declined 54.55% to Rs 0.05 crore in the quarter ended December 2024 as against Rs 0.11 crore during the previous quarter ended December 2023. Sales declined 14.04% to Rs 1.47 crore in the quarter ended December 2024 as against Rs 1.71 crore during the previous quarter ended December 2023. ParticularsQuarter EndedDec. 2024Dec. 2023% Var. Sales1.471.71 -14 OPM %4.088.19 - PBDT0.130.18 -28 PBT0.100.15 -33 NP0.050.11 -55 Powered by Capital Market - Live

4 months agoCapital Market - Live
Corporate
Colinz Laboratories to announce Quarterly Result

Colinz Laboratories will hold a meeting of the Board of Directors of the Company on 31 January 2025.Powered by Capital Market - Live

4 months agoCapital Market - Live
Earnings
Colinz Laboratories standalone net profit rises 33.33% in the September 2024 quarter

Net profit of Colinz Laboratories rose 33.33% to Rs 0.16 crore in the quarter ended September 2024 as against Rs 0.12 crore during the previous quarter ended September 2023. Sales rose 3.91% to Rs 1.86 crore in the quarter ended September 2024 as against Rs 1.79 crore during the previous quarter ended September 2023. ParticularsQuarter EndedSep. 2024Sep. 2023% Var. Sales1.861.79 4 OPM %9.146.70 - PBDT0.240.19 26 PBT0.210.16 31 NP0.160.12 33 Powered by Capital Market - Live

7 months agoCapital Market - Live
Corporate
Colinz Laboratories to table results

Colinz Laboratories will hold a meeting of the Board of Directors of the Company on 30 October 2024.Powered by Capital Market - Live

7 months agoCapital Market - Live
Corporate
Colinz Laboratories to hold AGM

Colinz Laboratories announced that the 38th Annual General Meeting (AGM) of the company will be held on 30 September 2024.Powered by Capital Market - Live

9 months agoCapital Market - Live
Corporate
Colinz Laboratories announces board meeting date

Colinz Laboratories will hold a meeting of the Board of Directors of the Company on 8 August 2024.Powered by Capital Market - Live

10 months agoCapital Market - Live

Colinz Laboratories standalone net profit rises 16.67% in the June 2024 quarter

10 months agoBusiness Standard

Frequently asked questions

Frequently asked questions

  1. What is the share price of Colinz Laboratories Ltd (COLINZ) today?

    The share price of COLINZ as on 10th June 2025 is ₹58.91. The stock prices are volatile and keep changing through the day depending upon various factors and market conditions.

  2. What is the return on Colinz Laboratories Ltd (COLINZ) share?

    The past returns of Colinz Laboratories Ltd (COLINZ) share are
    • Past 1 week: -7.79%
    • Past 1 month: 11.31%
    • Past 3 months: 13.53%
    • Past 6 months: -11.29%
    • Past 1 year: 39.07%
    • Past 3 years: 118.19%
    • Past 5 years: 740.37%

  3. What are the peers or stocks similar to Colinz Laboratories Ltd (COLINZ)?

    The peers or stocks similar to Colinz Laboratories Ltd (COLINZ) include:

  4. What is the market cap of Colinz Laboratories Ltd (COLINZ) share?

    Market capitalization, short for market cap, is the market value of a publicly traded company's outstanding shares. The market cap of Colinz Laboratories Ltd (COLINZ) is ₹14.84 Cr as of 10th June 2025.

  5. What is the 52 week high and low of Colinz Laboratories Ltd (COLINZ) share?

    The 52-week high of Colinz Laboratories Ltd (COLINZ) is ₹88.70 and the 52-week low is ₹40.20.

  6. What is the PE and PB ratio of Colinz Laboratories Ltd (COLINZ) stock?

    The P/E (price-to-earnings) ratio of Colinz Laboratories Ltd (COLINZ) is 29.10. The P/B (price-to-book) ratio is 1.66.

  7. Which sector does Colinz Laboratories Ltd (COLINZ) belong to?

    Colinz Laboratories Ltd (COLINZ) belongs to the Health Care sector & Pharmaceuticals sub-sector.

  8. How to buy Colinz Laboratories Ltd (COLINZ) shares?

    You can directly buy Colinz Laboratories Ltd (COLINZ) shares on Tickertape. Simply sign up, connect your demat account and place your order.